Antiangiogeneic Strategies in Mesothelioma.

Nowak, Anna K; Brosseau, Solenn; Cook, Alistair; Zalcman, Gérard

Nowak, Anna K; Brosseau, Solenn; Cook, Alistair; Zalcman, Gérard.

Afiliação

Nowak AK; National Centre for Asbestos Related Diseases, University of Western Australia, Crawley, WA, Australia.
Brosseau S; Medical School, University of Western Australia, Crawley, WA, Australia.
Cook A; Institute for Respiratory Health, University of Western Australia, Crawley, WA, Australia.
Zalcman G; Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, WA, Australia.

Front Oncol ; 10: 126, 2020.

Article em En | MEDLINE | ID: mdl-32133285

Palavras-chave

angiogenesis; bevacizumab; clinical trials; hypoxia; mesothelioma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Austrália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google